Reference is made to SoftOx's press release dated 14 August 2025 concerning the Equity Placement Facility Agreement with Long State Investments Ltd. (“Long State”). Certain shareholders, referred to as the Lending Shareholders, have entered into a share loan agreement (the “Agreement”) with Long State. This Agreement facilitates the lending of shares in SoftOx as part of the financing facility, whereby certain shareholders will lend a total of 60 000 000 shares to Long State over a period of 24 months from the start of the Equity Facility Placement Agreement, unless extended in accordance with its terms.
The lending shareholders will not receive any compensation for lending shares to Long State. However, SoftOx will reimburse them for documented expenses incurred by banks or brokers related to transactions executed as a result of this loan agreement.
The lending shareholders include the following primary insiders:
Sporcon Lifescience Advisors ApS, a company controlled by COB Ulrik Spork, has agreed to lend Long State 30 000 000 shares under the Agreement. In addition to the loaned shares, Sporcon Lifescience Advisors ApS holds 714 285 shares in SoftOx.
Thomas Bjarnsholt Holding ApS, a company controlled by CEO Thomas Bjarnsholt, has agreed to lend Long State 11 000 000 shares under the Agreement. In addition to the loaned shares, Thomas Bjarnsholt Holding ApS holds 470 574 shares in SoftOx.
Bonica AS, a company controlled by CFO Ingrid Juven, has agreed to lend Long State 5 000 000 shares under the Agreement. In addition to the loaned shares, Bonica AS holds 80 000 000 shares in SoftOx.
Enclosed with this announcement is the notification of transactions conducted by individuals with managerial responsibilities and their closely associated persons, in compliance with Regulation (EU) 2016/523.